SYMATESE helps you consolidate your leading position.
Create a premium medical device using our unique technology platforms in biopolymers and administration systems. Leverage our bovine collagen or cross-linked hyaluronic acid technologies. Market in all continents. Manufacture with a certified company. Work in confidence with an experienced partner with track record of successful projectsSet up a strong and lasting collaboration.
Also use our capabilities regarding other biopolymers
In the last 5 year more than 100 small and large companies benefited from our technologies
Set up a strong and lasting collaboration
SYMATESE’s strategy is to collaborate with companies willing to develop new medical devices. You can subcontract the design and/or production of your finished or semi-finished medical devices, through a tailor-made agreement, adapted to your specific situation and needs. With a solid financial situation, independent and historical shareholders, and a board management working together for more than 20 years, we are the right partner to answer any of your business opportunities.
Leverage our Research & Development
SYMATESE manufacturing operations are fully integrated in 4 plants: 3 based in France, 2 in Lyon area and one located near Paris plus one in Mauritius. They allow an optimal product quality, complying with GMP (good manufacturing practices). The Biopolymers manufacturing is managed with 2 specific production lines are each dedicated to the transformation of collagen and Hyaluronic Acid (HA) transformation, from raw material to sterile product (e.g packaged sterile prefilled syringes of cross-linked HA in blisters).
Manage your needs serenely with our manufacturing
SYMATESE manufacturing operations are fully integrated in our plant at Chaponost (Lyon – FRANCE) and take place in a controlled environment to allow an optimal product quality, complying with GMP (good manufacturing practices).
2 specific production lines are each dedicated to the transformation of collagen and Hyaluronic Acid (HA) transformation, from raw material to sterile product (e.g packaged sterile prefilled syringes of cross-linked HA in blisters)
Guarantee patients safety and optimize your worldwide presence
SYMATESE has always considered the quality of its products and the safety of patients as its main target, and has implemented an effective quality system to comply with the most stringent international regulatory requirements (ISO 13485 and QSR – 21 CFR part 820). Our daily goal is to ensure that patients receive a safe, high quality product meeting regulatory and legal requirements.
Every day, in all our activities, we are committed to moving towards excellence and performance.
English